- Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Research.
- Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993-2016. J Med Screen.
- Clinical validation of the cobas HPV test on the cobas 6800 system for the purpose of cervical screening. J Clin Microbiol.
- Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. J Am Soc Cytopathol.
- The projected timeframe until cervical cancer elimination in Australia. Lancet PH.
- Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: example from New Zealand. Vaccine.
- Should cervical cancer screening be performed before age 25? J Low Genit Tract Dis.
- The impact of ten years of HPV vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill.
- Australian Paediatric Surveillance Unit Annual Report, 2017. Commun Dis Intell Q Rep.
- Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. Cancer Epidemiol.
- Human papillomavirus vaccination update: nonavalent vaccine and the two-dose schedule. Australian Journal of General Practice.
- Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study. Vaccine.
- Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention. JMIR Res Protoc.
- Cervical screening in HPV-vaccinated populations. Climacteric.
- IPVS Statement Moving towards Elimination of Cervical Cancer as a Public Health Problem. Papillomavirus Research.
- Spatial variation in cervical cancer screening participation & outcomes among Indigenous and non-Indigenous Australians in Queensland. Geographical Research.
- Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Vaccine.
- Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012). PLoS One.
- Safety of human papillomavirus vaccines: An updated review. Drug Saf.
- National Cervical Screening Programme Annual Report 2015. National Screening Unit: Wellington.
- Authors’ reply to “Comments on: Safety of Human Papillomavirus Vaccines: An Updated Review”. Drug Saf.
- Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination. Journal of Infectious Diseases.
- Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia. PLoS ONE.
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia. BMJ Open.
- A prospective study of the incidence of juvenile onset recurrent respiratory papillomatosis after implementation of a National HPV Vaccination Program. J Infect Dis.
- Australia on-track to be the first country to achieve cervical cancer elimination.
- Self-collection for under-screened women as part of the renewed National Cervical Screening Program: A Pilot Study. Current Oncology.
- Completing the cervical screening pathway: An Australian pilot of HPV self-collection for under-screened and never-screened women. Current Oncology.
- Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Commun Dis Intell.
- Innovative approaches to cervical cancer screening in low- and middle-income countries. Climacteric.
- Ambiguous bodies, uncertain diseases: knowledge of cervical cancer in Papua New Guinea. Ethn Health.
- “Lest we forget” as we move forward with cervical screening. Aust N Z J Obstet Gynaecol.